Regulatory
510(k) Summary vs 510(k) Statement
In one line
Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Definition
A 510(k) Statement certifies that, following a substantial-equivalence determination, the submitter will provide all safety and effectiveness information within 30 days of any person’s request, including adverse information, excluding patient identifiers and trade-secret or confidential commercial information. A Summary meets 21 CFR 807.92 and is publicly available after clearance; do not promise same-day database posting.
Why it matters
Choice of Summary vs Statement has competitive and commercial implications. A well-written 510(k) Summary serves as marketing collateral, it's often the first technical document a hospital or competitor sees. A Statement provides less public visibility but creates an obligation to fulfill information requests within 30 days, which most companies underestimate. For high-profile or controversial products, the choice is often strategic.
Common pitfalls
- •Filing a Summary that is too thin, FDA expects substantial detail about indications, technological characteristics, performance testing, and substantial equivalence rationale.
- •Filing a Statement and then being unable to respond to information requests within 30 days, failure constitutes a violation.
- •Treating a 510(k) Summary as confidential or promising that FDA will publish it on the clearance date.
Sources